What is DSC (Differential Scanning Calorimetry) And How Is It Useful In Drug Development

Differential Scanning Calorimetry (DSC) is a thermal analysis technique widely used in drug development to study the thermal behaviour of substances, especially active pharmaceutical ingredients (APIs) and their interactions with excipients. It plays a crucial role in characterising materials, evaluating stability, and identifying potential formulation or compatibility issues early in the development process.

Understanding the thermal behaviour of drug substances and formulations is crucial for ensuring stability, efficacy, and safety during medicine development. One of the most powerful techniques used for this purpose is Differential Scanning Calorimetry (DSC). This thermal analysis method provides detailed information about the physical and chemical changes in drug compounds under controlled temperature conditions.

What is DSC (Differential Scanning Calorimetry)?

Differential Scanning Calorimetry (DSC) is a thermoanalytical technique used to measure the heat flow associated with phase transitions of a material as a function of temperature or time. It helps identify critical properties such as melting point, glass transition temperature, crystallisation, and purity—key factors in pharmaceutical formulation and processing.

Principle

The principle of DSC is based on the measurement of heat flow differences between a sample and an inert reference as both are subjected to the same controlled temperature program.

• As the temperature increases, the instrument detects endothermic (heat-absorbing) or exothermic (heat-releasing) transitions.
• These transitions may include melting, crystallisation, glass transitions, or chemical degradation.
• The resulting DSC curve (thermogram) plots heat flow vs. temperature, revealing the thermal behaviour of the substance.

Procedure

The basic steps in a DSC analysis are as follows:

1. Sample Preparation:
   • A small quantity (typically 1–10 mg) of the drug substance is weighed and sealed in an aluminium or platinum pan.
   • A reference pan, usually empty, is also prepared.
2. Loading into the DSC Instrument:
   • Both pans are placed in the DSC instrument’s furnace.
3. Programming the Temperature:
   • The temperature is increased at a controlled rate (e.g., 10°C/min) from ambient to a predetermined maximum (depending on the drug).
4. Measurement:
   • As the temperature rises, the instrument records differences in heat flow between the sample and the reference.
   • Thermal events, such as melting or the glass transition, are detected and recorded.
5. Data Analysis:
   • The thermogram is analysed to determine characteristic temperatures and enthalpy changes.

Representation of a DSC Thermograph

A DSC thermograph is typically a 2D plot with the following axes:

• X-axis: Temperature (°C or K) — shows the heating or cooling rate
• Y-axis: Heat flow (mW or J/g·K) — shows endothermic or exothermic events

Typical Features to Show on a DSC Thermograph:

How to Draw or Label It:

Visual Tip for Presentations:

Use labelled arrows or highlights on the graph to mark:

• Tg (glass transition temperature) – step or baseline shift
• Tm (melting temperature) – sharp endothermic peak
• ΔH (enthalpy change) – area under the curve

Case Study: Characterising Polymorphism in Carbamazepine

Background:
Carbamazepine, an anticonvulsant drug, exhibits polymorphism, existing in multiple crystalline forms. These forms can have significantly different solubility, stability, and bioavailability.

DSC Application:
Researchers used DSC to identify and distinguish between different polymorphs based on their melting points and enthalpies of fusion.

Findings:

• Form I: Melting point around 192°C
• Form III: Melting point around 175°C

The distinct thermal signatures enabled scientists to monitor polymorphic transitions during manufacturing and storage, ensuring consistency in the final product.

Applications in Drug Development

DSC is widely applied across different stages of drug development:

1. Preformulation Studies:

• Determine the melting point and glass transition temperature.
• Assess polymorphism and compatibility with excipients.

2. Stability Testing:

• Detect thermal degradation or transitions over time or under stress conditions.

3. Formulation Development:

• Monitor amorphous vs. crystalline content in solid dispersions.
• Optimise lyophilised (freeze-dried) formulations.

4. Quality Control:

• Verify batch consistency and purity.
• Ensure no undesirable transitions occur during processing.

Limitations

While DSC is highly useful, it does have some limitations:

Conclusion

Differential Scanning Calorimetry (DSC) plays an indispensable role in modern drug development. By providing insights into thermal behaviors, phase transitions, and material compatibility, DSC supports informed decisions during formulation, stability testing, and quality assurance. While it has certain limitations, its strengths make it a staple in pharmaceutical thermal analysis and material characterization.

You May Like:

1. Relative Response Factor (RRF) in Pharmaceutical Analysis
2. How To Control Impurities In Pharmaceuticals: Get Mastery In 11 Minutes
3. How To Calculate Potency, Purity and Assay In Pharmaceuticals

FAQs

What is the use of DSC in pharmaceuticals?

DSC is used in pharmaceuticals to study the thermal behaviour of drug substances and formulations. It helps determine melting points, glass transitions, polymorphism, stability, and compatibility with excipients, critical for drug development and quality control.

What is the difference between purity determined by DSC and chemical purity?

Purity by DSC refers to thermal purity, estimated based on melting point depression caused by impurities, typically useful for assessing crystalline substances. It provides insight into physical purity, but it is an approximation and assumes ideal behaviour.
Chemical purity, on the other hand, is measured using techniques like HPLC or titration and quantifies the actual chemical composition, detecting both organic and inorganic impurities, regardless of their thermal behaviour.

Further Reading

• Comparison of the Four Anhydrous Polymorphs of …:
  • by AL Grzesiak · 2003 · Cited by 622 — Herein, we report the single crystal X-ray structure of form I (triclinic) of CBZ and compare the physical properties of the four anhydrous polymorphs of this …
  • 12 pages
• Physical Characterisation of Pharmaceutical Solids, Edited by Harry G. Brittain,